Adaptive Biotechnologies Corporation announced that Tycho Peterson will depart the company as CFO. Kyle Piskel, the company's Principal Accounting Officer, will succeed Peterson as full-time CFO. Piskel served as the company's interim CFO from February to June 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | +5.77% | +9.56% | -43.88% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.88% | 405M | |
-20.55% | 10.81B | |
+47.97% | 3.36B | |
-32.75% | 2.22B | |
-14.15% | 2.16B | |
-26.06% | 1.55B | |
+19.85% | 1.04B | |
-2.62% | 746M | |
-31.67% | 425M | |
+29.03% | 378M |
- Stock Market
- Equities
- ADPT Stock
- News Adaptive Biotechnologies Corporation
- Adaptive Biotechnologies Corporation Announces CFO Changes